Search research articles
Contact Us
Filters
Showing results (361-370 of 410) with videos related to
Page
of 41
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2021
Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial
M Annala, S Fu, J V W Bacon, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
November 9, 2019
Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum
Fred Saad, Christina Canil, Antonio Finelli, et al.
Pediatric Blood & Cancer
|
November 3, 2020
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma
Karen D Wright, Xiaopan Yao, Wendy B London, et al.
The Lancet. Digital Health
|
May 27, 2026
Artificial intelligence analysis of temporalis muscle thickness for monitoring sarcopenia and clinical outcomes in individuals with paediatric brain tumours: a retrospective cohort study
Anna Zapaishchykova, John Zielke, Divyanshu Tak, et al.
JCO Global Oncology
|
November 4, 2022
IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer
Lorelei A Mucci, Jacob Vinson, Theresa Gold, et al.
European Urology
|
April 1, 2019
Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer
William S Chen, Rahul Aggarwal, Li Zhang, et al.
European Urology Oncology
|
October 1, 2025
Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis
Karan Parekh, Kim van der Zande, Sarah W S Ng, et al.
Cancer Research
|
June 8, 2023
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Arian Lundberg, Meng Zhang, Rahul Aggarwal, et al.
Cancer Research
|
December 25, 2016
MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2
Rajdeep Das, Philip A Gregory, Rayzel C Fernandes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2018
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
Rahul Aggarwal, Jiaoti Huang, Joshi J Alumkal, et al.
Page
of 41
Search research articles
Search
Showing results (361-370 of 410) with videos related to
Sort By:
Page
of 41
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2021
Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial
M Annala, S Fu, J V W Bacon, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
November 9, 2019
Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum
Fred Saad, Christina Canil, Antonio Finelli, et al.
Pediatric Blood & Cancer
|
November 3, 2020
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma
Karen D Wright, Xiaopan Yao, Wendy B London, et al.
The Lancet. Digital Health
|
May 27, 2026
Artificial intelligence analysis of temporalis muscle thickness for monitoring sarcopenia and clinical outcomes in individuals with paediatric brain tumours: a retrospective cohort study
Anna Zapaishchykova, John Zielke, Divyanshu Tak, et al.
JCO Global Oncology
|
November 4, 2022
IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer
Lorelei A Mucci, Jacob Vinson, Theresa Gold, et al.
European Urology
|
April 1, 2019
Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer
William S Chen, Rahul Aggarwal, Li Zhang, et al.
European Urology Oncology
|
October 1, 2025
Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis
Karan Parekh, Kim van der Zande, Sarah W S Ng, et al.
Cancer Research
|
June 8, 2023
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Arian Lundberg, Meng Zhang, Rahul Aggarwal, et al.
Cancer Research
|
December 25, 2016
MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2
Rajdeep Das, Philip A Gregory, Rayzel C Fernandes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2018
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
Rahul Aggarwal, Jiaoti Huang, Joshi J Alumkal, et al.
Page
of 41